South San Francisco, CA, United States of America

Claire L Neilan

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.4

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Claire L Neilan: Innovator in Cancer Treatment

Introduction

Claire L Neilan is a prominent inventor based in South San Francisco, CA. She has made significant contributions to the field of cancer treatment through her innovative research and development of pharmaceutical compounds. With a total of 2 patents, her work focuses on targeting specific mechanisms involved in cancer progression.

Latest Patents

Neilan's latest patents include groundbreaking inventions aimed at inhibiting DNA polymerase theta and developing combination therapies for cancer treatment. One of her notable patents is for "Thiadiazolyl derivatives as DNA polymerase theta inhibitors and uses thereof." This patent discloses compounds that inhibit DNA Polymerase Theta (Polθ) activity, particularly by targeting the ATP-dependent helicase domain activity of Polθ. The implications of this research are significant, as it offers potential methods for treating diseases such as cancer, especially homologous recombination (HR) deficient cancers. Another important patent is for a "Combination therapy comprising a MAT2A inhibitor and a type II PRMT inhibitor." This combination product is designed to treat various cancers, including solid tumors, by utilizing a methionine adenosyltransferase II alpha (MAT2A) inhibitor alongside a Type II protein arginine methyltransferase (Type II PRMT) inhibitor.

Career Highlights

Throughout her career, Claire has worked with notable companies in the biotechnology and pharmaceutical sectors. She has been associated with Ideaya Biosciences, Inc. and GlaxoSmithKline Intellectual Property Limited, where she has contributed her expertise in drug development and innovation.

Collaborations

Neilan has collaborated with esteemed colleagues, including Marcus Michael Fischer and Michael Patrick Dillon, to advance her research and enhance the impact of her inventions.

Conclusion

Claire L Neilan's contributions to cancer treatment through her innovative patents highlight her role as a leading inventor in the field. Her work continues to pave the way for new therapeutic strategies that could significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…